financetom
Business
financetom
/
Business
/
Lithium Ionic Reports Positive Drill Results from Bandeira Project in Brazil
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lithium Ionic Reports Positive Drill Results from Bandeira Project in Brazil
Dec 3, 2024 5:36 AM

08:13 AM EST, 12/03/2024 (MT Newswires) -- Lithium Ionic ( LTHCF ) reported Tuesday positive new drill results from its flagship Bandeira lithium project in Brazil.

Highlights include 16.00 meters grading 1.77% lithium oxide, 19.60 meters grading 1.33% lithium oxide and 14.00 meters grading 1.81% lithium oxide.

"These latest results from Bandeira underscore the continued growth potential of our flagship project, with well-mineralized pegmatite extensions and entirely new zones into previously untested areas," CEO Blake Hylands said. "This new data not only reinforces our confidence in the resource but increases our near surface resources which presents optimization opportunities with strengthening and expanding the already robust Bandeira mining plan."

The company said it continues to advance permits for the project, with the Licenca Ambiental Concomitante application, submitted in late 2023, is currently in the final stages of review by the Minas Gerais State Secretariat for the Environment and Sustainable Development.

"With key milestones on the horizon, we remain focused on advancing Lithium Ionic ( LTHCF ) toward becoming Brazil's next major lithium producer," Hylands said.

The company's share price dropped 2.2% yesterday to $0.88 on the TSXV.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Labcorp to Serve as NOWDiagnostics' Exclusive US Distributor for 'First To Know' Syphilis Test
Labcorp to Serve as NOWDiagnostics' Exclusive US Distributor for 'First To Know' Syphilis Test
Oct 17, 2024
11:08 AM EDT, 10/16/2024 (MT Newswires) -- Labcorp Holdings ( LH ) will be the exclusive distributor of NOWDiagnostics' First To Know syphilis test in the US under a collaboration between the companies, NOWDiagnostics said Wednesday. NOWDiagnostics said Labcorp ( LH ) will also be its US distribution partner for the ADEXUSDx pregnancy test that is presently used in hospital...
Optime Care Expands Partnership with Rigel Pharmaceuticals
Optime Care Expands Partnership with Rigel Pharmaceuticals
Oct 17, 2024
11:07 AM EDT, 10/16/2024 (MT Newswires) -- Optime Care said Wednesday it has expanded its partnership with Rigel Pharmaceuticals ( RIGL ) to include the commercial distribution of Tavalisse, an oral medicine to help patients manage chronic immune thrombocytopenia. Optime Care, an AscellaHealth Company, said it also manage commercial distribution of Rigel's Gavreto and Rezlidhia products. Rigel shares were up...
Elemental Altus Royalties Consolidates Ownership of Royalty Portfolio in US$28 Million Deal
Elemental Altus Royalties Consolidates Ownership of Royalty Portfolio in US$28 Million Deal
Oct 17, 2024
11:07 AM EDT, 10/16/2024 (MT Newswires) -- Elemental Altus Royalties ( ELEMF ) on Wednesday agreed to acquire an additional 50% ownership of 24 existing royalties from AlphaStream for US$28 million in equity. The portfolio includes Elemental Altus' existing producing gold royalties on the Bonikro gold project, the Ballarat mine, the South Kalgoorlie operations and 21 additional royalties located in...
Update: Wave Life Sciences Shares Soar After Reporting Positive Proof-of-Mechanism Data From WVE-006 Study
Update: Wave Life Sciences Shares Soar After Reporting Positive Proof-of-Mechanism Data From WVE-006 Study
Oct 17, 2024
11:08 AM EDT, 10/16/2024 (MT Newswires) -- (Updates stock move in the headline and the first paragraph.) Wave Life Sciences ( WVE ) shares surged 78% in recent Wednesday trading after it reported positive proof-of-mechanism data from an ongoing phase 1b/2a study of WVE-006 in alpha-1 antitrypsin deficiency. The biotech firm said WVE-006 was developed with its oligonucleotide chemistry platform...
Copyright 2023-2025 - www.financetom.com All Rights Reserved